IL150392A0 - Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl - Google Patents

Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl

Info

Publication number
IL150392A0
IL150392A0 IL15039200A IL15039200A IL150392A0 IL 150392 A0 IL150392 A0 IL 150392A0 IL 15039200 A IL15039200 A IL 15039200A IL 15039200 A IL15039200 A IL 15039200A IL 150392 A0 IL150392 A0 IL 150392A0
Authority
IL
Israel
Prior art keywords
hydroxyclohexyl
hydroxbenzoate
dimethylaminomethyl
phenyl
esters derived
Prior art date
Application number
IL15039200A
Other languages
English (en)
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Publication of IL150392A0 publication Critical patent/IL150392A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL15039200A 1999-12-30 2000-12-26 Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl IL150392A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000060A ES2160534B1 (es) 1999-12-30 1999-12-30 Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
PCT/ES2000/000486 WO2001049650A1 (es) 1999-12-30 2000-12-26 Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil)fenilo

Publications (1)

Publication Number Publication Date
IL150392A0 true IL150392A0 (en) 2002-12-01

Family

ID=8491916

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15039200A IL150392A0 (en) 1999-12-30 2000-12-26 Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl

Country Status (30)

Country Link
US (1) US6894076B2 (sh)
EP (1) EP1251120B1 (sh)
JP (1) JP2003519208A (sh)
KR (1) KR20020063281A (sh)
CN (1) CN1414946A (sh)
AP (1) AP1234A (sh)
AT (1) ATE284380T1 (sh)
AU (1) AU775918B2 (sh)
BG (1) BG106883A (sh)
BR (1) BR0016882A (sh)
CA (1) CA2395976A1 (sh)
CZ (1) CZ20022189A3 (sh)
DE (1) DE60016631D1 (sh)
EA (1) EA004770B1 (sh)
EE (1) EE200200365A (sh)
ES (1) ES2160534B1 (sh)
HR (1) HRP20020559A2 (sh)
HU (1) HUP0204147A3 (sh)
IL (1) IL150392A0 (sh)
IS (1) IS6440A (sh)
MA (1) MA26862A1 (sh)
MX (1) MXPA02006514A (sh)
NO (1) NO20023098D0 (sh)
NZ (1) NZ520263A (sh)
OA (1) OA12132A (sh)
PL (1) PL356056A1 (sh)
SK (1) SK9252002A3 (sh)
WO (1) WO2001049650A1 (sh)
YU (1) YU50902A (sh)
ZA (1) ZA200205193B (sh)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
EP2273983B1 (en) 2008-05-09 2016-07-20 Grünenthal GmbH Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
PL2456427T3 (pl) 2009-07-22 2015-07-31 Gruenenthal Gmbh Wytłaczana na gorąco postać dawki o kontrolowanym uwalnianiu
PL2456424T3 (pl) 2009-07-22 2013-12-31 Gruenenthal Gmbh Stabilizowana przed utlenianiem odporna na naruszenie postać dawkowania
EP2383255A1 (en) 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
AU2011297901B2 (en) 2010-09-02 2014-07-31 Grunenthal Gmbh Tamper resistant dosage form comprising inorganic salt
MX2013002293A (es) 2010-09-02 2013-05-09 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico.
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
US20130028972A1 (en) 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
PE20141638A1 (es) 2011-07-29 2014-11-22 Gruenenthal Chemie Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
EA201401139A1 (ru) 2012-04-18 2015-03-31 Грюненталь Гмбх Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
DK3354649T3 (da) 2015-10-15 2020-02-24 Jiangsu Hengrui Medicine Co Oxaspiroderivat, fremstillingsmetode derfor og anvendelser deraf i lægemidler

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3562589A (en) * 1968-09-09 1971-02-09 Ite Imperial Corp Electrically resetting undervoltage trip for circuit breakers
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
DE19525137C2 (de) 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
GB9924604D0 (en) * 1999-10-18 1999-12-22 European Molecular Biology Lab Embl Genetic switch

Also Published As

Publication number Publication date
MA26862A1 (fr) 2004-12-20
AP1234A (en) 2003-12-28
MXPA02006514A (es) 2004-07-30
HUP0204147A3 (en) 2003-10-28
NO20023098L (no) 2002-06-26
EA200200614A1 (ru) 2002-12-26
BG106883A (en) 2003-05-30
AU2012601A (en) 2001-07-16
YU50902A (sh) 2006-01-16
CZ20022189A3 (cs) 2003-03-12
JP2003519208A (ja) 2003-06-17
US6894076B2 (en) 2005-05-17
NO20023098D0 (no) 2002-06-26
ATE284380T1 (de) 2004-12-15
WO2001049650A1 (es) 2001-07-12
HRP20020559A2 (en) 2004-02-29
PL356056A1 (en) 2004-06-14
ES2160534A1 (es) 2001-11-01
EE200200365A (et) 2003-10-15
NZ520263A (en) 2004-07-30
SK9252002A3 (en) 2003-04-01
BR0016882A (pt) 2002-11-05
CA2395976A1 (en) 2001-07-12
OA12132A (en) 2006-05-05
IS6440A (is) 2002-06-25
KR20020063281A (ko) 2002-08-01
EA004770B1 (ru) 2004-08-26
DE60016631D1 (de) 2005-01-13
ZA200205193B (en) 2003-06-27
EP1251120B1 (en) 2004-12-08
AU775918B2 (en) 2004-08-19
US20030100598A1 (en) 2003-05-29
CN1414946A (zh) 2003-04-30
AP2002002571A0 (en) 2002-09-30
ES2160534B1 (es) 2002-04-16
HUP0204147A2 (hu) 2003-04-28
EP1251120A1 (en) 2002-10-23

Similar Documents

Publication Publication Date Title
IL150392A0 (en) Novel esters derived from (rr, ss)-2-(hydroxbenzoate of 3-(2-dimethylaminomethyl-1-hydroxyclohexyl) phenyl
AU6900200A (en) System for fabrication of indirect dental restoratives
AU2115301A (en) Dental compositions
AU2611600A (en) Dental cast tray assembly
AU6687900A (en) Phenoxy fluoropyrimidines
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
AUPQ197899A0 (en) Biomedical compositions
EG24052A (en) Novel processes for the preparation of (r)-a (2,3-demethoxyphenyl-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethapnol
AU4991300A (en) Processes for the synthesis of oligomers using phusphoramidite compositions
AU1601801A (en) Methods of preparing crna
EP1072296A3 (en) Video game
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
ITMI992048A0 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabi cicloalcani
AU2829700A (en) Processes for the preparation of alpha-aminoketones
GB0029650D0 (en) Proces for the preparation of 1,1-cyclopropanedicarboxylic diesters
AU6550800A (en) Hepoxilin analogs
AU7711800A (en) Novel uses of 2-bromopalmitate
AU3860600A (en) Ceramic compositions
AU2002312514A1 (en) Hoxd3 compositions ad methods for improved wound healing
AU6017900A (en) Novel tumor suppressor gene
AU2510101A (en) The manufacture of improved support matrices
AU4144900A (en) Method of the utilization of bactericidal composition
ITMI992457A0 (it) Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidrois ochinolin-3-carbossiammide
AU3158801A (en) Novel vaccine composition
AU2002232061A1 (en) Compositions having improved bioavailability of eletriptan

Legal Events

Date Code Title Description
HP Change in proprietorship